RS57108B1 - Derivati izoindolina za upotrebu u lečenju virusne infekcije - Google Patents

Derivati izoindolina za upotrebu u lečenju virusne infekcije

Info

Publication number: RS57108B1
Authority: RS; Serbia
Prior art keywords: treatment; viral infection; isoindoline derivatives; isoindoline; derivatives
Prior art date: 2014-07-08

Application number

RS20180469A

Other languages

English (en)

Inventor

Brian Alvin Johns

Emile Johann Velthuisen

Jason Gordon Weatherhead

Lita Suwandi

David Temelkoff

Original Assignee

Viiv Healthcare Uk Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2014-07-08

Filing date

2015-07-06

Publication date

2018-06-29

2015-07-06 Application filed by Viiv Healthcare Uk Ltd filed Critical Viiv Healthcare Uk Ltd

2018-06-29 Publication of RS57108B1 publication Critical patent/RS57108B1/sr

Links

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/44—Iso-indoles; Hydrogenated iso-indoles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/4035—Isoindoles, e.g. phthalimide
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
- C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
- C07D407/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
- C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
- C07D407/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a carbon chain containing aromatic rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/08—Bridged systems
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains three hetero rings
- C07D487/14—Ortho-condensed systems
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/06—Peri-condensed systems
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D498/08—Bridged systems
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F5/00—Compounds containing elements of Groups 3 or 13 of the Periodic System
- C07F5/02—Boron compounds
- C07F5/025—Boronic and borinic acid compounds

RS20180469A 2014-07-08 2015-07-06 Derivati izoindolina za upotrebu u lečenju virusne infekcije RS57108B1 (sr)

Applications Claiming Priority (5)

Application Number	Priority Date	Filing Date	Title
US201462021844P	2014-07-08	2014-07-08
US201462064615P	2014-10-16	2014-10-16
US201562134616P	2015-03-18	2015-03-18
PCT/IB2015/055095 WO2016005878A1 (en)	2014-07-08	2015-07-06	Isoindoline derivatives for use in the treatment of a viral infection
EP15742106.6A EP3166925B1 (en)	2014-07-08	2015-07-06	Isoindoline derivatives for use in the treatment of a viral infection

Publications (1)

Publication Number	Publication Date
RS57108B1 true RS57108B1 (sr)	2018-06-29

Family

ID=53724405

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
RS20180469A RS57108B1 (sr)	2014-07-08	2015-07-06	Derivati izoindolina za upotrebu u lečenju virusne infekcije

Country Status (36)

Country	Link
US (1)	US10112899B2 (sr)
EP (1)	EP3166925B1 (sr)
JP (1)	JP2017521428A (sr)
KR (1)	KR20170024115A (sr)
CN (1)	CN106795141A (sr)
AU (1)	AU2015287334B2 (sr)
BR (1)	BR112017000246A2 (sr)
CA (1)	CA2954603A1 (sr)
CL (1)	CL2017000014A1 (sr)
CR (1)	CR20170005A (sr)
CY (1)	CY1120607T1 (sr)
DK (1)	DK3166925T3 (sr)
DO (1)	DOP2016000336A (sr)
EA (1)	EA030204B8 (sr)
ES (1)	ES2667793T3 (sr)
HK (1)	HK1231466A1 (sr)
HR (1)	HRP20180639T1 (sr)
HU (1)	HUE037884T2 (sr)
IL (1)	IL249520A0 (sr)
LT (1)	LT3166925T (sr)
MA (1)	MA40221A (sr)
ME (1)	ME03066B (sr)
MX (1)	MX2017000312A (sr)
PE (1)	PE20170440A1 (sr)
PH (1)	PH12016502559A1 (sr)
PL (1)	PL3166925T3 (sr)
PT (1)	PT3166925T (sr)
RS (1)	RS57108B1 (sr)
RU (1)	RU2016150326A (sr)
SG (1)	SG11201610746SA (sr)
SI (1)	SI3166925T1 (sr)
TR (1)	TR201807217T4 (sr)
TW (1)	TW201617331A (sr)
UY (1)	UY36204A (sr)
WO (1)	WO2016005878A1 (sr)
ZA (1)	ZA201608554B (sr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP3144311A4 (en)	2014-05-16	2018-01-03	Shionogi & Co., Ltd.	Tricyclic heterocyclic derivative having hiv replication-inhibiting effect
SG11201709634QA (en)	2015-05-29	2017-12-28	Shionogi & Co	Nitrogen-containing tricyclic derivative having hiv replication inhibitory activity
TW201720798A (zh) *	2015-09-17	2017-06-16	Ｖｉｉｖ醫療保健英國有限公司	苯并氮呯衍生物
EP3383863A1 (en) *	2015-12-04	2018-10-10	ViiV Healthcare UK Limited	Isoindoline derivatives
US20180327355A1 (en) *	2015-12-04	2018-11-15	Viiv Healthcare Uk Limited	Isoindoline derivatives
EP3383862A1 (en) *	2015-12-04	2018-10-10	ViiV Healthcare UK Limited	Isoindoline derivatives
GB201604647D0 (en)	2016-03-18	2016-05-04	Mission Therapeutics Ltd	Novel compounds
WO2018020357A1 (en)	2016-07-25	2018-02-01	Viiv Healthcare Uk Limited	Indoline derivatives
WO2018051250A1 (en)	2016-09-14	2018-03-22	Viiv Healthcare Company	Combination comprising tenofovir alafenamide, bictegravir and 3tc

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US7405237B2 (en) *	2004-07-28	2008-07-29	Celgene Corporation	Isoindoline compounds and methods of their use
DE102007028521A1 (de) *	2007-06-21	2008-12-24	Merck Patent Gmbh	Indazolamidderivate
DE102007041116A1 (de)	2007-08-30	2009-03-05	Merck Patent Gmbh	1,3-Dihydro-isoindolderivate
US8338441B2 (en)	2009-05-15	2012-12-25	Gilead Sciences, Inc.	Inhibitors of human immunodeficiency virus replication
GB0908394D0 (en)	2009-05-15	2009-06-24	Univ Leuven Kath	Novel viral replication inhibitors
JP6055468B2 (ja) *	2011-07-15	2016-12-27	ヴィーブヘルスケアユーケーリミテッド	アザインドール化合物及びｈｉｖを治療するための方法
CN102491932A (zh) *	2011-12-26	2012-06-13	天津科技大学	一种3-吲哚啉酮类衍生物及其制备方法及其应用
WO2013103738A1 (en) *	2012-01-04	2013-07-11	Gilead Sciences, Inc.	Napthalene acetic acid derivatives against hiv infection
US9006235B2 (en) *	2012-03-06	2015-04-14	Bristol-Myers Squibb Company	Inhibitors of human immunodeficiency virus replication
AR090760A1 (es) *	2012-04-20	2014-12-03	Gilead Sciences Inc	Compuestos de benzotiazol y su uso contra el virus de hiv
ES2647437T3 (es) *	2012-07-12	2017-12-21	Viiv Healthcare Uk Limited	Compuestos y procedimientos para tratar el VIH

2015
- 2015-07-06 WO PCT/IB2015/055095 patent/WO2016005878A1/en active Application Filing
- 2015-07-06 BR BR112017000246A patent/BR112017000246A2/pt not_active IP Right Cessation
- 2015-07-06 CA CA2954603A patent/CA2954603A1/en not_active Abandoned
- 2015-07-06 DK DK15742106.6T patent/DK3166925T3/en active
- 2015-07-06 PT PT157421066T patent/PT3166925T/pt unknown
- 2015-07-06 RU RU2016150326A patent/RU2016150326A/ru not_active Application Discontinuation
- 2015-07-06 UY UY0001036204A patent/UY36204A/es not_active Application Discontinuation
- 2015-07-06 ME MEP-2018-109A patent/ME03066B/me unknown
- 2015-07-06 EP EP15742106.6A patent/EP3166925B1/en active Active
- 2015-07-06 PE PE2017000008A patent/PE20170440A1/es not_active Application Discontinuation
- 2015-07-06 PL PL15742106T patent/PL3166925T3/pl unknown
- 2015-07-06 ES ES15742106.6T patent/ES2667793T3/es active Active
- 2015-07-06 CN CN201580048182.2A patent/CN106795141A/zh active Pending
- 2015-07-06 TR TR2018/07217T patent/TR201807217T4/tr unknown
- 2015-07-06 KR KR1020177003445A patent/KR20170024115A/ko unknown
- 2015-07-06 HU HUE15742106A patent/HUE037884T2/hu unknown
- 2015-07-06 MX MX2017000312A patent/MX2017000312A/es unknown
- 2015-07-06 EA EA201692358A patent/EA030204B8/ru not_active IP Right Cessation
- 2015-07-06 RS RS20180469A patent/RS57108B1/sr unknown
- 2015-07-06 LT LTEP15742106.6T patent/LT3166925T/lt unknown
- 2015-07-06 MA MA040221A patent/MA40221A/fr unknown
- 2015-07-06 JP JP2017500900A patent/JP2017521428A/ja active Pending
- 2015-07-06 TW TW104121895A patent/TW201617331A/zh unknown
- 2015-07-06 AU AU2015287334A patent/AU2015287334B2/en not_active Ceased
- 2015-07-06 CR CR20170005A patent/CR20170005A/es unknown
- 2015-07-06 SI SI201530238T patent/SI3166925T1/en unknown
- 2015-07-06 US US15/314,549 patent/US10112899B2/en not_active Expired - Fee Related
- 2015-07-06 SG SG11201610746SA patent/SG11201610746SA/en unknown
2016
- 2016-12-12 IL IL249520A patent/IL249520A0/en unknown
- 2016-12-12 ZA ZA2016/08554A patent/ZA201608554B/en unknown
- 2016-12-21 PH PH12016502559A patent/PH12016502559A1/en unknown
- 2016-12-28 DO DO2016000336A patent/DOP2016000336A/es unknown
2017
- 2017-01-04 CL CL2017000014A patent/CL2017000014A1/es unknown
- 2017-05-17 HK HK17104954.7A patent/HK1231466A1/zh unknown
2018
- 2018-04-23 HR HRP20180639TT patent/HRP20180639T1/hr unknown
- 2018-05-23 CY CY181100550T patent/CY1120607T1/el unknown

Also Published As

Publication number	Publication date
PL3166925T3 (pl)	2018-08-31
CL2017000014A1 (es)	2017-06-23
LT3166925T (lt)	2018-06-11
RU2016150326A (ru)	2018-08-08
EA201692358A1 (ru)	2017-06-30
PH12016502559A1 (en)	2017-04-17
CA2954603A1 (en)	2016-01-14
SG11201610746SA (en)	2017-01-27
IL249520A0 (en)	2017-02-28
ES2667793T3 (es)	2018-05-14
ZA201608554B (en)	2018-11-28
EP3166925B1 (en)	2018-03-14
EP3166925A1 (en)	2017-05-17
AU2015287334B2 (en)	2017-08-31
CN106795141A (zh)	2017-05-31
EA030204B1 (ru)	2018-07-31
JP2017521428A (ja)	2017-08-03
KR20170024115A (ko)	2017-03-06
MX2017000312A (es)	2017-04-27
UY36204A (es)	2016-01-29
US20180244617A1 (en)	2018-08-30
ME03066B (me)	2019-01-20
US10112899B2 (en)	2018-10-30
TW201617331A (zh)	2016-05-16
BR112017000246A2 (pt)	2018-03-27
SI3166925T1 (en)	2018-06-29
EA030204B8 (ru)	2018-08-31
CY1120607T1 (el)	2019-12-11
CR20170005A (es)	2017-05-08
WO2016005878A1 (en)	2016-01-14
PT3166925T (pt)	2018-05-24
HK1231466A1 (zh)	2017-12-22
DK3166925T3 (en)	2018-06-18
PE20170440A1 (es)	2017-05-09
DOP2016000336A (es)	2017-02-28
HRP20180639T1 (hr)	2018-06-29
TR201807217T4 (tr)	2018-06-21
MA40221A (fr)	2018-03-14
AU2015287334A1 (en)	2017-01-12
HUE037884T2 (hu)	2018-09-28

Publication	Publication Date	Title
IL272820B (en)	2021-09-30	The history of sulfamoylpyrrolamide and their use as drugs to treat jaundice b
IL280459A (en)	2021-03-01	Phosphoramidates for the treatment of hepatitis B virus
HRP20180639T1 (hr)	2018-06-29	Derivati izoindolina, namijenjeni upotrebi u liječenju virusne infekcije
ZA201700952B (en)	2018-12-19	Indoles for use in influenza virus infection
SG11201700962SA (en)	2017-04-27	Disposable diaper
ZA201701643B (en)	2018-12-19	Pyrrolopyrimidines for use in influenza virus infection
SG11201505434WA (en)	2016-08-30	Disposable diaper
SG11201408640RA (en)	2015-05-28	Disposable diaper
PT3105236T (pt)	2017-12-22	Macrociclos de benzotiazole como inibidores da replicação do vírus da imunodeficiência humana
SG11201408634UA (en)	2015-05-28	Disposable diaper
SG11201703330YA (en)	2017-05-30	Iminosugars useful for the treatment of viral diseases
PL3017799T3 (pl)	2019-09-30	Stół dla pacjenta
EP3197465A4 (en)	2018-04-25	Compositions and methods for treating a viral infection
AU360378S (en)	2015-02-19	Disposable diaper
AU360276S (en)	2015-02-13	Disposable diaper
AU2014903253A0 (en)	2014-09-04	Viral therapy